£8.3M
The funding round was led by S28 Capital with participation from Vectr Ventures and DIP Capital.
S28 Capital + 2 others
Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 2 November 2026.
Announcements
1,179
Total raised
£24.7B
disclosed amounts
This month
£9.0M
raised so far
The funding round was led by S28 Capital with participation from Vectr Ventures and DIP Capital.
Active Partners led the Series A round to fund global expansion for the London-based e-jeweller.
"With Active Partners on board we now believe we have the external capital and expertise to complement our amazing team to succeed in growing the business and owning the ‘bespoke’ space in fine jewellery."
Nexthash led the £2.5m investment to help the software engineer learning platform establish a global footprint.
"Skills Matter is a great example of a highly scalable, internationally facing growth business actively disrupting its sector. It is pioneering new, pedagogical methods to help global tech talent strive for continued progress as we head into the 2020s. Today, Skills Matter already reaches 1% of the global professional software engineering population and are uniquely positioned to take a significant slice of a global multi-billion dollar market for technology talent and skills, and we are proud to be able to help them on their journey."
Atomico led the Series A investment to support geographic expansion and team growth.
"Despite being critical infrastructure for our society, childcare has been overlooked for far too long. We’ve already seen how profoundly our services can improve the well-being of families, as well as older adults and children who have a chance to connect with another generation while working. We’re excited for Atomico to help us scale our vision of building a completely new way of doing childcare so even more families can benefit."
Epidarex Capital led the Series A round for the drug toxicity testing specialist.
"Since its inception, Clyde Biosciences has been working hard to meet our clients’ needs in improving outcomes in drug development. This investment, led by Epidarex Capital, will help propel Clyde Biosciences to a new level, allowing us to strengthen our team, reinforce our commercial offering and broaden our geographic reach. We welcome the support of our investment partners and look forward to an exciting future."